Covered recipient · General Payments record
MARK RYAN KAUTH
General Payments · PY2022–2024
$662.73
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.79 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $138.74 | 3 |
| ABIOMED | $71.12 | 2 |
| Abbott Laboratories | $48.56 | 2 |
| Medtronic, Inc. | $24.43 | 1 |
| Acerta Pharma LLC | $21.97 | 1 |
| PFIZER INC. | $13.63 | 1 |
| Actelion Pharmaceuticals US, Inc. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $31.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1122123567 | CMS |
| Abbott Laboratories | $17.01 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1122127403 | CMS |
| ABIOMED | $52.59 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142262591 | CMS |
| ABIOMED | $18.53 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142262619 | CMS |
| Actelion Pharmaceuticals US, Inc. | $13.34 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078887193 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.97 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110511746 | CMS |
| Boston Scientific Corporation | $24.90 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092509955 | CMS |
| Boston Scientific Corporation | $88.41 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092509959 | CMS |
| Boston Scientific Corporation | $25.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092509957 | CMS |
| Medtronic, Inc. | $24.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116873269 | CMS |
| PFIZER INC. | $13.63 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131111889 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.